A randomized controlled trial of movement strategies compared with exercise for people with Parkinson's disease
β Scribed by Meg E. Morris; Robert Iansek; Beth Kirkwood
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 89 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
This randomized controlled clinical trial was conducted to compare the effects of movement rehabilitation strategies and exercise therapy in hospitalized patients with idiopathic Parkinson's disease. Participants were randomly assigned to a group that received movement strategy training or musculoskeletal exercises during 2 consecutive weeks of hospitalization. The primary outcome was disability as measured by the Unified Parkinson's Disease Rating Scale, UPDRS (motor and ADL components). Secondary outcomes were balance, walking speed, endurance, and quality of life. Assessments were carried out by blinded testers at baseline, after the 2 weeks of treatment and 3 months after discharge. The movement strategy group showed improvements on several outcome measures from admission to discharge, including the UPDRS, 10 m walk, 2 minute walk, balance, and PDQ39. However, from discharge to follow up there was significant regression in performance on the 2 minute walk and PDQ39. For the exercise group, quality of life improved significantly during inpatient hospitalization and this was retained at followβup. Inpatient rehabilitation produces short term reductions in disability and improvements in quality of life in people with Parkinson's disease. Β© 2008 Movement Disorder Society
π SIMILAR VOLUMES
## Abstract This randomized controlled trial with blinded assessment aimed to determine the effect of a 6βmonth minimally supervised exercise program on fall risk factors in people with Parkinson's disease (PD). Fortyβeight participants with PD who had fallen or were at risk of falling were randomi
## Abstract The objective of this study is to investigate the safety and tolerability of memantine, a glutamatergic modulator, in patients suffering from dementia associated with Parkinson's disease (PDD), an increasingly common complication of PD. This was a 22βweek trial of 25 participants with a
## Abstract Irrespective of limited evidence, not only traditional physiotherapy, but also a wide array of complementary methods are applied by patients with Parkinson's disease (PD). We evaluated the immediate and sustained effects of Qigong on motor and nonmotor symptoms of PD, using an addβon de
## Abstract Twenty patients with Parkinson's disease and marked intellectual impairment or dementia participated in a doubleβblind placebo controlled trial of the nootropic, piracetam. A standardized neurological examination, a neuropsychological test battery, and a functional scale, The Sickness I